Neoplasia/BPH

	Prediction of residual disease after chemotherapy in advanced NSGCT - does microRNA provide clinical benefits? Klin Onkol Pokriv, Hrstka R, , Lakomý R, Poprach A, Staník M, Babánková I, K, Kiss I. PMID: 42975996 [PubMed - indexed for MEDLINE]
	Can a negative PSMA PET/CT limit the indication for lymphadenectomy in patients with localized moderate- and high-risk prostate cancer? Klin Onkol Dianová K, , Paldus V. PMID: 42975993 [PubMed - indexed for MEDLINE]
	AÂ European multicenter cohort study of patients with oligometastatic prostate cancer receiving stereotactic body radiotherapy for non-spinal bone metastases. Strahlenther Onkol Nägler F, Schäfer S, Seiler I, von Wachter C, Balermpas P, Loi M, Simontacchi G, Slavik M, Burkon P, Meents J, Giordano FA, Lohaus F, Willner J, Schunn AS, Drabke S, Klischies K, Wittenstein O, Bank P, Partl R, Müller JA, Gawish A, Grün A, Baehr A, Trommer M, Gkika E, Mader T, Holy R, Dzierma Y, Ehret F, Rühle A, Guckenberger M, Moustakis C, Brunner T, Blanck O, Nicolay NH, Boda-Heggemann J, Kästner L. PMID: 42975650 [PubMed - as supplied by publisher]
	Comparison of Traumatic Complications following Prostate Biopsy in Men with Lower Urinary Tract Symptoms Due to Prostate Disease Using Biopty Gun versus Semiautomatic Needle. Niger Postgrad Med J Onyebum OV, Ugwumba FO, Amu OC, Okoh AD, Nnadozie UU, Maduba CC, Odo C, Ulebe AO. PMID: 42975224 [PubMed - indexed for MEDLINE]
	Short communication: Urinary schistosomiasis mimicking a bladder tumour in a Somali student diagnosed in TÃ¼rkiye. J Helminthol Ünal B, , , Bedir S. PMID: 42974862 [PubMed - indexed for MEDLINE]
	TexTNet: a texture-guided hierarchical architecture for prostate cancer Gleason segmentation in whole slide images. Front Med (Lausanne) Arshad M, Chengliang W, Wajeeh Us Sima M, Shaikh JA, Alkhalaf S, Alturise F. PMID: 42973807 [PubMed]
	Beyond morphology: Toward integrated risk assessment in urinary cytology. Cancer Cytopathol Wojcik EM. PMID: 42973121 [PubMed - indexed for MEDLINE]
	Fully automated AI-based quantification of tumour volume on PSMA PET-CT images is associated with overall survival in prostate cancer. Clin Physiol Funct Imaging Wittgren J, Ingvar J, Enqvist O, Larsson M, Minarik D, Edenbrandt L, Bjartell A, Trägårdh E. PMID: 42973055 [PubMed - indexed for MEDLINE]
	Five-Year Clinical Outcomes Following Nephrectomy for Renal Cell Carcinoma: Evidence From a Nationwide Japanese Surgical Registry. Int J Urol Mizuno R, Yamamoto K, Yamamoto H, Hatakeyama S, Sakamoto S, Yasui T, Kobayashi T, Kamoto T, Kikuchi E, Ito A, Kume H. PMID: 42972879 [PubMed - indexed for MEDLINE]
	Acute Lymphopenia and Recovery With Prophylactic Pelvic Nodal Radiotherapy in Oligometastatic Prostate Cancer: Interim Results From the Prospective PROLONG2 Cohort. Cancer Med Qi X, Wang H, Zhang H, Ren X, Ma M, Li X, Zhang W, He Z, Song Y, Shen C, Yu W, Fan Y, Gao X, Li H. PMID: 42972866 [PubMed - indexed for MEDLINE]
	Prognostic impact of variants of uncertain significance (VUS) in BRCA genes and homologous recombination repair (HRR) genes in prostate cancer: a real-world multicenter study. BMC Med Garofoli M, Natalicchio MI, Bruno G, Rosano A, Maiorano BA, Rossetti S, Scagliarini S, Incorvaia L, Formisano L, Toma I, Giordano G, Pecoraro G, Grillone F, Palumbo L, Pisino M, Palladino M, Di Pippo CR, Bafunno V, Brighi N, Casadei C, Lolli C, Cursano MC, Chiuri VE, Rescigno P, Tamburini E, Sanguedolce F, Calabrò F, De Giorgi U, Landriscina M, Conteduca V. PMID: 42972372 [PubMed - indexed for MEDLINE]
	When, where, and in whom does recurrence occur after radical cystectomy for pathologically confirmed non-muscle-invasive bladder cancer? Implications for risk-adapted surveillance. World J Urol Contieri R, de Angelis M, Scilipoti P, Pellegrino F, Longoni M, Afferi L, Zamboni S, Suardi N, Subiela JD, Musi G, Di Trapani E, Mistretta FA, D'Andrea D, Laukhtina E, Soria F, Gontero P, Del Giudice F, Beatrici E, De Groote R, Mottrie A, Rouprêt M, Grobet-Jeandin E, Baudewyns A, Tanaka H, Proietti F, Simone G, Schulz GB, Pyrgidis N, Ploussard G, Antonelli A, Bertolo R, Roumiguié M, Bajeot AS, Mir MC, Umari P, Teoh JYC, Pichler R, Mori K, , Poyet C, Albisinni S, Aziz A, Shariat SF, Minervini A, Mari A, Lambertini L, Aveta A, Spena G, Izzo A, Montorsi F, Briganti A, Pradere B, van Rhijn BWG, Hurle R, Claps F, Perdonà S, PeMoschinirdonà M, Mertens LS, European Association of Urology. PMID: 42972136 [PubMed - indexed for MEDLINE]
	Difficulties with early prostate cancer diagnosis: a multi-perspective mixed-methods study. Br J Gen Pract Hiscock J, Formby L, Din N, Hendry A, Wilkinson CE. PMID: 42971714 [PubMed - as supplied by publisher]
	External Validation of Existing Nomograms on Indian Prostate Biopsy Data. Int J Urol Gupta M, Arulraj K, Kumar R. PMID: 42971147 [PubMed - indexed for MEDLINE]
	Predictive Nomogram for High Ki-67 Expression using Contrast-Enhanced Ultrasound of Clear Cell Renal Cell Carcinoma. J Imaging Inform Med Meng X, Yang Y, Yun Y, Shao Y, Jian Y, Sun Z. PMID: 42970198 [PubMed - as supplied by publisher]
	Pre-treatment machine learning prediction of local failure and time to local failure after Gamma Knife radiosurgery for radioresistant brain metastases. J Neurooncol Reyes JS, Shohayeb MAM, Bouras A, Lunsford LD, Hadjipanayis CG, Niranjan A. PMID: 42970176 [PubMed - indexed for MEDLINE]
	Robot-Assisted Radical Prostatectomy Using the Hugo RAS System: The First 15 Cases by a First-Year Novice Surgeon Without Prior Console Experiences. Int J Med Robot Yang CH, Barbulescu DV, Marian L, Kim YA, Wu CH, Narasimhan R, Ou YC, Lin CC. PMID: 42969321 [PubMed - indexed for MEDLINE]
	Real-World Early Prostate-Specific Antigen Response Comparison Among Patients with Metastatic Castration Sensitive Prostate Cancer Treated with Apalutamide or Abiraterone Acetate in the United States. J Health Econ Outcomes Res Lowentritt B, Bilen MA, Burbage S, Patel C, Kinkead F, Rossi C, Wong G, Pilon D, Shore N. PMID: 42968988 [PubMed]
	From Biopsy to Pathology: A Retrospective Cohort Study of Predictors of Gleason Score Upgrading in Grade Group 1 Prostate Cancer. Cancer Diagn Progn Su HC, Su YC, Lee HY, Juan YS, Wu WJ, Lu K. PMID: 42968951 [PubMed]
	Correction to "Chidamide (a Histone Deacetylase Inhibitor) Plus Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Phase Ib Trial". MedComm (2020) PMID: 42968886 [PubMed]

Articles 1 - 20 / 192582

Page 1 of 9630



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy